Fagron Q3 Revenue Surges 23.2% on Acquisitions, North America Hit by Recall

Fagron reported a 23.2% revenue increase in Q3 2026, driven by organic growth and acquisitions in Asia and Brazil, but North American operations were hampered by a sector-wide IV bag recall. The company expects volumes to recover in Q4 and maintains its full-year revenue guidance of €1.125-1.150 billion. The recall's impact on margins and the pace of recovery remain uncertain.